UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | K | L | M | N | O | P | R | S | T | W | Z
Number of items: 61.

A

AbdulJabbar, K; Raza, SEA; Rosenthal, R; Jamal-Hanjani, M; Veeriah, S; Akarca, A; Lund, T; ... Yuan, Y; + view all (2020) Geospatial immune variability illuminates differential evolution of lung adenocarcinoma. Nature Medicine , 26 pp. 1054-1062. 10.1038/s41591-020-0900-x. Green open access
file

Ahern, A; Griffin, S; Wheeler, G; Sharp, S; Aveyard, P; Boyland, E; Halford, J; (2020) The effect of referral to an open-group behavioural weight management programme on the relative risk of normoglycaemia, non-diabetic hyperglycaemia and type 2 diabetes: secondary analysis of the WRAP trial. Diabetes, Obesity and Metabolism , 22 (11) pp. 2069-2076. 10.1111/dom.14123. Green open access
file

Angelis, A; Naci, H; Hackshaw, A; (2020) Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies. Pharmacoeconomics 10.1007/s40273-020-00956-w. (In press). Green open access
file

B

Balestrini, S; Koepp, MJ; Gandhi, S; Rickman, HM; Yen Shin, G; Houlihan, CF; Anders-Cannon, J; ... Sisodiya, SM; + view all (2020) Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy. Epilepsy & Behavior , Article 107602. 10.1016/j.yebeh.2020.107602. (In press).

Bishton, MJ; Rule, S; Wilson, W; Turner, D; Patmore, R; Clifton-Hadley, L; McMillan, A; ... Haynes, A; + view all (2020) The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival. British Journal of Haematology , 190 (4) pp. 545-554. 10.1111/bjh.16555. Green open access
file

Blagden, SP; Cook, AD; Poole, C; Howells, L; McNeish, IA; Dean, A; Kim, J-W; ... Clamp, AR; + view all (2020) Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial. The Lancet Oncology , 21 (7) pp. 969-977. 10.1016/S1470-2045(20)30218-7. Green open access
file

Booth, S; Plaschkes, H; Kirkwood, AA; Gibb, A; Horgan, P; Higham, C; Oladipo, JM; ... Eyre, TA; + view all (2020) Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma. Blood Advances , 4 (18) pp. 4337-4346. 10.1182/bloodadvances.2020002553. Green open access
file

Bray, T; Sakai, N; Dudek, A; Fisher, C; Rajesparan, K; Lopes, A; Ciurtin, C; ... Hall-Craggs, M; + view all (2020) Histographic Analysis of Oedema and Fat in Inflamed Bone Marrow based on Quantitative MRI. European Radiology , 313 10.1007/s00330-020-06785-x. Green open access
file

Brazil, L; Swampillai, AL; Mak, KM; Edwards, D; Mesiri, P; Clifton-Hadley, L; Shaffer, R; ... Short, SC; + view all (2020) Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial. Neuro-Oncology Advances , 2 (1) 10.1093/noajnl/vdaa046. Green open access
file

Burnett, T; Mozgunov, P; Pallmann, P; Villar, SS; Wheeler, GM; Jaki, T; (2020) Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs. BMC Medicine , 18 , Article 352. 10.1186/s12916-020-01808-2. Green open access
file

C

Colombo, I; Zaccarelli, E; Del Grande, M; Tomao, F; Multinu, F; Betella, I; Ledermann, JA; ... Colombo, N; + view all (2020) ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies. ESMO Open , 5 , Article e000827. 10.1136/esmoopen-2020-000827. Green open access
file

Colombo, N; Oza, AM; Lorusso, D; Aghajanian, C; Oaknin, A; Dean, A; Weberpals, JI; ... Coleman, RL; + view all (2020) The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma. Gynecologic Oncology 10.1016/j.ygyno.2020.05.045. (In press). Green open access
file

D

Dehbi, H-M; Hackshaw, A; (2020) Sample size calculation in randomised phase II selection trials using a margin of practical equivalence. Trials , 21 , Article 301. 10.1186/s13063-020-04248-8. Green open access
file

E

Elyashiv, O; Ledermann, J; Parmar, G; Farrelly, L; Counsell, N; Feeney, A; El-Khouly, F; ... Nicum, S; + view all (2020) ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy. International Journal of Gynecologic Cancer 10.1136/ijgc-2020-002073. (In press). Green open access
file

Eyre, TA; Djebbari, F; Kirkwood, AA; Collins, GP; (2020) Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review. Haematologica , 105 (7) pp. 1914-1924. 10.3324/haematol.2019.229948. Green open access
file

F

Fennell, D; Danson, S; Woll, P; Forster, M; Talbot, D; Child, J; Farrelly, L; ... Wheeler, G; + view all (2020) Ganetespib in combination with pemetrexed-platinum chemotherapy in patients with pleural Mesothelioma (MESO-02): A phase Ib trial. Clinical Cancer Research , 26 (18) pp. 4748-4755. 10.1158/1078-0432.CCR-20-1306. Green open access
file

Fenwick, JD; Landau, DB; Baker, AT; Bates, AT; Eswar, C; Garcia-Alonso, A; Harden, SV; ... Counsell, N; + view all (2020) Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics , 106 (4) pp. 733-742. 10.1016/j.ijrobp.2019.11.397. Green open access
file

Fox, TA; Troy-Barnes, E; Kirkwood, AA; Chan, WY; Day, J; Chavda, SJ; Kumar, EA; ... Ardeshna, KM; + view all (2020) Clinical outcomes and risk factors for severe COVID‐19 infection in patients with haematological disorders receiving chemo‐ or immunotherapy. British Journal of Haematology , 191 (2) pp. 194-206. 10.1111/bjh.17027. Green open access
file

Fox, TA; Troy-Barnes, E; Kirkwood, AA; Chan, WY; Day, JW; Chavda, SJ; Kumar, EA; ... Ardeshna, KM; + view all (2020) Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'. British Journal of Haematology , 191 (3) pp. 505-506. 10.1111/bjh.17110.

G

Gewandter, JS; Dworkin, RH; Turk, DC; Devine, EG; Hewitt, D; Jensen, MP; Katz, NP; ... Witter, J; + view all (2020) Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations. The Journal of Pain , 21 (9-10) pp. 931-942. 10.1016/j.jpain.2019.12.003. Green open access
file

Ghorani, E; Reading, JL; Henry, JY; Massy, MRD; Rosenthal, R; Turati, V; Joshi, K; ... Quezada, SA; + view all (2020) The T cell differentiation landscape is shaped by tumour mutations in lung cancer. Nature Cancer , 1 (5) pp. 546-561. 10.1038/s43018-020-0066-y. Green open access
file

Glynne-Jones, R; Meadows, HM; Lopes, A; Muirhead, R; Sebag-Montefiore, D; Adams, R; ACTII study group; (2020) Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus. Results of a post-hoc analysis from the randomized phase III ACT II trial. Annals of Oncology , 31 (10) pp. 1376-1385. 10.1016/j.annonc.2020.06.012. Green open access
file

Glynne-Jones, R; Meadows, HM; Lopes, A; Riddle, P; Duggan, M; Sebag-Montefiore, D; McDonald, A; ... Adams, R; + view all (2020) A Phase I/II Feasibility Study of Intravenous Cetuximab in Combination with 5 days Weekly Oral Capecitabine and Preoperative Radiotherapy in Rectal Cancer (XERXES). Archives of Clinical and Biomedical Research , 4 (4) pp. 394-412. 10.26502/acbr.50170112. Green open access
file

Gourley, C; Miller, RE; Hollis, RL; Ledermann, JA; (2020) Role of Poly (ADP-Ribose) Polymerase inhibitors beyond BReast CAncer Gene-mutated ovarian tumours: definition of homologous recombination deficiency? Current Opinion in Oncology , 32 (5) pp. 442-450. 10.1097/CCO.0000000000000660. Green open access
file

Grayling, MJ; Wheeler, GM; (2020) A review of available software for adaptive clinical trial design. Clinical Trials 10.1177/1740774520906398. (In press). Green open access
file

H

Hainsworth, EG; Shahmanesh, M; Stevenson, F; (2020) Insights into the social context of living with a dual diagnosis of HIV and cancer: a qualitative, thematic analysis of popular discourse in London newspapers. AIDS Care , 32 (6) pp. 793-799. 10.1080/09540121.2019.1653444. Green open access
file

Hall, MR; Dehbi, H-M; Banerjee, S; Lord, R; Clamp, A; Ledermann, JA; Nicum, S; ... Rustin, G; + view all (2020) A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer. Gynecologic Oncology 10.1016/j.ygyno.2020.09.048. (In press).

Harter, P; Pautier, P; Van Nieuwenhuysen, E; Reuss, A; Redondo, A; Lindemann, K; Kurzeder, C; ... Marme, F; + view all (2020) Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34). International Journal of Gynecologic Cancer 10.1136/ijgc-2020-001572. (In press). Green open access
file

Hutchison, I; Hackshaw, A; (2020) Reply to Comment(s) on "Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort". British Journal of Cancer , 123 pp. 1200-1201. 10.1038/s41416-020-0983-7. Green open access
file

I

Illidge, TM; Phillips, EH; Counsell, N; Pettengell, R; Johnson, PWM; Culligan, DJ; Popova, B; ... Radford, J; + view all (2020) Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma. Blood Advances , 4 (1) pp. 203-206. 10.1182/bloodadvances.2019001023. Green open access
file

K

Koutoukidis, DA; Land, J; Hackshaw, A; Heinrich, M; McCourt, O; Beeken, RJ; Philpott, S; ... Yong, KL; + view all (2020) Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design. British Journal of Cancer 10.1038/s41416-020-0866-y. (In press). Green open access
file

Koutoukidis, DA; Land, J; Hackshaw, A; Heinrich, M; McCourt, O; Beeken, RJ; Philpott, S; ... Yong, KL; + view all (2020) Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design. British Journal of Cancer 10.1038/s41416-020-0866-y. (In press). Green open access
file

L

Land, J; McCourt, O; Heinrich, M; Beeken, RJ; Koutoukidis, DA; Paton, B; Yong, K; ... Fisher, A; + view all (2020) The adapted Zelen was a feasible design to trial exercise in myeloma survivors. Journal of Clinical Epidemiology , 125 pp. 76-83. 10.1016/j.jclinepi.2020.04.004. Green open access
file

Laszlo, HE; Seward, E; Ayling, R; Lake, J; Malhi, A; Hackshaw, A; Stephens, C; ... Machesney, M; + view all (2020) Quantitative faecal immunochemical test for patients with 'high risk' bowel symptoms: a prospective cohort study. MedRxiv: Cold Spring Harbor, NY, USA. Green open access
file

Lechner, M; Counsell, N; Liu, J; Eynon-Lewis, N; Paun, S; Lund, VJ; Jayaraj, S; (2020) Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection. Lancet Microbe , 1 (4) , Article e150. 10.1016/S2666-5247(20)30096-3. Green open access
file

Lechner, M; Liu, J; Counsell, N; Ta, NH; Rocke, J; Anmolsingh, R; Eynon-Lewis, N; ... Philpott, C; + view all (2020) Course of symptoms for loss of sense of smell and taste over time in one thousand forty-one healthcare workers during the Covid-19 pandemic: Our experience. Clinical Otolaryngology 10.1111/coa.13683. (In press).

Ledermann, JA; Oza, AM; Lorusso, D; Aghajanian, C; Oaknin, A; Dean, A; Colombo, N; ... Coleman, RL; + view all (2020) Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial. Lancet Oncology , 21 (5) pp. 710-722. 10.1016/S1470-2045(20)30061-9. Green open access
file

Lee, A; (2020) Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. Cancer Discovery 10.1158/2159-8290.CD-20-0773. (In press). Green open access
file

Lee, LYW; Cazier, J-B; Starkey, T; Briggs, SEW; Arnold, R; Bisht, V; Booth, S; ... UK Coronavirus Cancer Monitoring Project Team; + view all (2020) COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. The Lancet Oncology , 21 (10) pp. 1309-1316. 10.1016/S1470-2045(20)30442-3. Green open access
file

Litchfield, K; Reading, JL; Lim, EL; Xu, H; Liu, P; Al-Bakir, M; Wong, YNS; ... Swanton, C; + view all (2020) Escape from nonsense-mediated decay associates with anti-tumor immunogenicity. Nature Communications , 11 , Article 3800. 10.1038/s41467-020-17526-5. Green open access
file

Litchfield, K; Stanislaw, S; Spain, L; Gallegos, LL; Rowan, A; Schnidrig, D; Rosenbaum, H; ... Turajlic, S; + view all (2020) Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue. Cell Reports , 31 (5) p. 107550. 10.1016/j.celrep.2020.107550. Green open access
file

López, S; Lim, EL; Horswell, S; Haase, K; Huebner, A; Dietzen, M; Mourikis, TP; ... McGranahan, N; + view all (2020) Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution. Nature Genetics , 52 (3) pp. 283-293. 10.1038/s41588-020-0584-7. Green open access
file

M

Mandair, D; Khan, MS; Lopes, A; Furtado O'Mahony, L; Ensell, L; Lowe, H; Hartley, JA; ... Meyer, T; + view all (2020) Prognostic threshold for circulating tumour cells in patients with pancreatic and midgut neuroendocrine tumours. Journal of Clinical Endocrinology and Metabolism 10.1210/clinem/dgaa822. (In press).

McLeavy, L; Rahman, B; Kristeleit, R; Ledermann, J; Lockley, M; McCormack, M; Mould, T; ... Lanceley, A; + view all (2020) Mainstreamed Genetic Testing in Ovarian Cancer: Patient Experience of the Testing Process. International Journal of Gynecological Cancer , 30 (2) pp. 221-226. 10.1136/ijgc-2019-000630. Green open access
file

McMillan, AK; Phillips, EH; Kirkwood, AA; Barrans, S; Burton, C; Rule, S; Patmore, R; ... Linch, DC; + view all (2020) Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial. Annals of Oncology 10.1016/j.annonc.2020.05.016. (In press). Green open access
file

McNamara, MG; Lopes, A; Wasan, H; Malka, D; Goldstein, D; Shannon, J; Okusaka, T; ... Valle, JW; + view all (2020) Landmark survival analysis and impact of anatomic origin in prospective clinical trials of biliary tract cancer. Journal of Hepatology , 73 (5) pp. 1109-1117. 10.1016/j.jhep.2020.05.014. Green open access
file

Miller, RE; Leary, A; Scott, CL; Serra, V; Lord, CJ; Bowtell, D; Chang, DK; ... Yates, LR; + view all (2020) ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer. Annals of Oncology , 31 (12) pp. 1606-1622. 10.1016/j.annonc.2020.08.2102. Green open access
filefilefilefilefilefilefilefile

Mirza, MR; Benigno, B; Dørum, A; Mahner, S; Bessette, P; Barceló, IB; Berton-Rigaud, D; ... Matulonis, UA; + view all (2020) Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial. Gynecologic Oncology 10.1016/j.ygyno.2020.09.006. (In press). Green open access
file

Mitchell, E; Goodman, K; Hartley, S; Hickey, H; McDonald, AM; Meadows, HM; Rhodes, S; ... UK Trial Managers’ Network Executive Group; + view all (2020) Where do we go from here? – Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals. Trials , 21 , Article 384. 10.1186/s13063-020-04316-z. Green open access
file

Moorman, AV; Schwab, C; Winterman, E; Hancock, J; Castleton, A; Cummins, M; Gibson, B; ... Vora, A; + view all (2020) Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion. British Journal of Haematology 10.1111/bjh.17093. (In press). Green open access
file

N

Newton, C; Nordin, A; Rolland, P; Ind, T; Larsen-Disney, P; Martin-Hirsch, P; Beaver, K; ... Fotopoulou, C; + view all (2020) British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU). International Journal of Gynecologic Cancer , 30 (5) pp. 695-700. 10.1136/ijgc-2019-001176. Green open access
file

O

Oza, AM; Lorusso, D; Aghajanian, C; Oaknin, A; Dean, A; Colombo, N; Weberpals, JI; ... Coleman, RL; + view all (2020) Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma. Journal of Clinical Oncology 10.1200/JCO.19.03107. (In press). Green open access
filefile

P

Pinato, DJ; Lee, AJX; Biello, F; Seguí, E; Aguilar-Company, J; Carbó, A; Bruna, R; ... Gennari, A; + view all (2020) Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe. Cancers , 12 (7) , Article 1841. 10.3390/cancers12071841. Green open access
file

Post, CCB; de Boer, SM; Powell, ME; Mileshkin, L; Katsaros, D; Bessette, P; Haie-Meder, C; ... Creutzberg, CL; + view all (2020) Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial. International Journal of Radiation Oncology - Biology - Physics 10.1016/j.ijrobp.2020.10.030. (In press). Green open access
file

R

Roncolato, FT; O'Connell, R; Joly, F; Lanceley, A; Hilpert, L; Buizen, L; Okamoto, E; ... Friedlander, ML; + view all (2020) Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(> 3) chemotherapy – the GCIG Symptom Benefit Study (SBS). Gynecologic Oncology , 156 (1) pp. 45-53. 10.1016/j.ygyno.2019.10.001. Green open access
file

S

Shah, V; Sherborne, AL; Johnson, DC; Ellis, S; Price, A; Chowdhury, F; Kendall, J; ... on behalf of NCRI Haematology Clinical Studies Group; + view all (2020) Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients. Leukemia 10.1038/s41375-020-0750-z. Green open access
file

Sng, CCT; Wong, YNS; Wu, A; Ottaviani, D; Chopra, N; Galazi, M; Benafif, S; ... Shaw, H; + view all (2020) Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience. Frontiers in Oncology , 10 , Article 595804. 10.3389/fonc.2020.595804. Green open access
file

T

Tan, WS; Teo, CH; Chan, D; Ang, KM; Heinrich, M; Feber, A; Sarpong, R; ... DETECT II trial collaborators, .; + view all (2020) Exploring patients’ experience and perception of being diagnosed with bladder cancer: A mixed methods approach. BJU International , 125 (5) pp. 669-678. 10.1111/bju.15008. Green open access
filefile

Tjokrowidjaja, A; Lee, CK; Friedlander, M; Gebski, V; Gladieff, L; Ledermann, J; Penson, R; ... Pujade-Lauraine, E; + view all (2020) Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy. European Journal of Cancer , 139 pp. 59-67. 10.1016/j.ejca.2020.08.021. Green open access
file

W

Waterhouse, JV; Hull, JH; Linch, M; (2020) Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat? European Urology 10.1016/j.eururo.2020.04.027. (In press). Green open access
file

Z

Zakeri, K; Rotolo, F; Lacas, B; Vitzthum, LK; Le, Q-T; Gregoire, V; Overgaard, J; ... MARCH/MACH-NC Collaborative Group and the Head and Neck Cancer I; + view all (2020) Predictive classifier for intensive treatment of head and neck cancer. Cancer 10.1002/cncr.33212. (In press). Green open access
file

This list was generated on Wed Oct 13 00:57:20 2021 BST.